MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma | MicrobiomeTrials← Back to trialsNCT05655312
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2023-06-01Est. Completion: 2027-12-31
Enrollment target: 300 participants Locations- University of California Irvine, Orange, California, United States
- Mayo Clinic, Jacksonville, Florida, United States
- University of Miami, Miami, Florida, United States
- Sarasota Memorial Hospital, Sarasota, Florida, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kentucky, Lexington, Kentucky, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
- Saint Louis University Hospital, St Louis, Missouri, United States
- Washington University of St. Louis, St Louis, Missouri, United States
- Nebraska Cancer Specialists, Omaha, Nebraska, United States
- Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
- University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States
Other microbiome trials you might be interested in
MelanomaGliomaThyroid CancerNon-Small Cell Lung CancerMalignant NeoplasmsBrain NeoplasmsAdvanced or Metastatic Solid TumorsHGGLGGLow Grade GliomaHigh Grade GliomaDifferentiated Thyroid CancerNSCLC (Non-small Cell Lung Cancer)
The purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in co…
Birmingham, United StatesEst. completion Aug 2, 2027
Contact
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Esophageal CarcinomaGastroesophageal Junction AdenocarcinomaHepatocellular CarcinomaLocally Advanced Urothelial CarcinomaLung Non-Small Cell CarcinomaMalignant Solid NeoplasmMetastatic Colorectal CarcinomaMetastatic Cutaneous MelanomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Urothelial CarcinomaRecurrent Esophageal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage IV Renal Cell Cancer AJCC v8Unresectable Cutaneous MelanomaUnresectable Esophageal Squamous Cell CarcinomaUrothelial CarcinomaUnresectable Urothelial Carcinoma
This phase II trial compares the impact of subcutaneous (SC) nivolumab given in an in-home setting to an in-clinic setti…
Jacksonville, United StatesEst. completion Dec 31, 2026